Han Zheng Visits LinkDoc Technology, Urges Homegrown Innovation in Big Data and AI
VCBeat (WeChat ID: vcbeat) has learned that on June 20, Xinwen Lianbo reported: Han Zheng, Member of the Standing Committee of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, conducted field research in Tianjin Municipality on June 19 to assess progress in the coordinated development of the Beijing-Tianjin-Hebei region. During the visit, Vice Premier Han visited enterprises such as LinkDoc Technology (Tianjin) Co., Ltd. to gain insights into their independent innovation-driven development. He was accompanied by government officials including Li Hongzhong, Member of the Political Bureau of the CPC Central Committee and Secretary of the Tianjin Municipal Party Committee; Zhang Guoqing, Deputy Secretary of the Tianjin Municipal Party Committee and Mayor of Tianjin Municipality; and Zhang Yuzhuo, Secretary of the Binhai New Area Party Committee of Tianjin.
Han Zheng, Member of the Standing Committee of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, Visits LinkDoc Technology
Promoting the coordinated development of the Beijing-Tianjin-Hebei region is a major national strategy and a highly complex systemic project, in which big data has played a significant role. In 2016, the state launched the Beijing-Tianjin-Hebei Big Data Comprehensive Pilot Zone to provide decision-making support and drive development for the region’s coordinated growth. As a leading enterprise in China’s medical big data and artificial intelligence industry, LinkDoc Technology, with the support and guidance of Tianjin Municipality, the Tianjin Binhai New Area, and the Economic-Technological Development Area, has actively contributed to the construction of the Beijing-Tianjin-Hebei Big Data Comprehensive Pilot Zone. It has demonstrated exemplary leadership in big data infrastructure development, the practical application of medical AI, and the cultivation of health and medical industrial clusters, achieving remarkable results.
Founded in 2014, LinkDoc Technology is dedicated to exploring the research, development, and application of medical big data and artificial intelligence, guided by its founding philosophy of “assisting healthcare providers and benefiting patients.” Over three years, LinkDoc has assembled a cross-disciplinary team of more than 1,000 professionals spanning medicine, scientific research, technology, and industry services. The company provides comprehensive big data solutions to medical institutions, regulatory authorities, governments at all levels, as well as pharmaceutical companies and insurance organizations, thereby advancing the development of medical big data in China.
Member of the Standing Committee of the Political Bureau and Vice Premier Han Zheng Heard a Report from Zhang Tianze, CEO of LinkDoc Technology
In his report, Zhang Tianze, CEO of LinkDoc Technology, noted that in recent years, both China and the United States have been vying for leadership in the healthcare data industry. As a hub for innovation in the healthcare sector, data serves as a valuable “industrial resource” and “infrastructure.” To ensure the development of high-quality data resources and infrastructure, LinkDoc Technology has undertaken extensive innovation and technological R&D since 2015, resulting in exponential growth in its data processing volume. By the first half of 2018, the penetration rate of single-cancer-type coverage on LinkDoc’s medical big data platform had reached 60%, whereas the penetration rate among cancer patients across North America was only 3%. This indicates that China has significantly surpassed the United States in its capacity to develop oncology data resources.
Building on a solid foundation of data governance and technical reserves, LinkDoc Technology has, since 2018, realized the value delivery and monetization of its data assets through multiple avenues, including the deployment of AI-assisted diagnostic and therapeutic applications, driving the upgrade of “Internet + Healthcare,” and activating innovative services for the pharmaceutical industry.
To alleviate the strain on China’s medical resources, LinkDoc Technology fully leverages big data and AI technologies to enhance clinical diagnosis and treatment standards, reduce healthcare costs, and ensure that all patients have access to affordable, precise medical services.
At the Chest Imaging AI Interpretation Event hosted by the Thoracic Surgeons Branch of the Chinese Medical Doctor Association in April this year, the LinkDoc AI Intelligent Diagnostic System for Pulmonary Nodules achieved a 20% higher average diagnostic accuracy than thoracic surgeons from renowned Grade A tertiary hospitals, while reducing diagnostic time by 25%. This demonstrates that LinkDoc’s AI-assisted diagnosis and treatment capabilities have reached or even surpassed the level of top-tier domestic experts. Moving forward, AI-assisted diagnosis at this level will be developed and extended to various types of tumors, benefiting millions of cancer patients in China and saving hundreds of billions in unnecessary medical expenditures for society and the nation.
To facilitate the widespread adoption of the latest AI-assisted diagnosis and treatment systems across China’s healthcare system, LinkDoc Technology has fully leveraged its role as a platform for internet hospitals. As one of the first service providers in China to obtain a national license for internet hospital operations, LinkDoc Technology effectively integrates AI, big data, and internet hospital services to deliver comprehensive, precision management for patients with critical illnesses. This initiative promotes the decentralization of high-quality medical resources, enhances the proficiency and service capabilities of primary care hospitals and medical personnel, and enables patients in second- and third-tier cities or primary healthcare institutions to access medical services comparable to those offered by top-tier hospitals.
Politburo Standing Committee Member and Vice Premier Han Zheng Inspects LinkDoc Technology’s Data Operations Center
After listening to Zhang Tianze’s report, Han Zheng, Member of the Standing Committee of the Political Bureau and Vice Premier, visited LinkDoc Technology’s Data Operations Center and Patient Follow-up Center to gain firsthand insights into its operations, and expressed affirmation for LinkDoc Technology’s development.
With the support of the Tianjin Municipal Science and Technology Commission, LinkDoc Technology has reached a cooperation consensus with Tianjin Chest Hospital to jointly establish the first AI-assisted diagnosis and treatment platform for lung cancer in the Beijing-Tianjin-Hebei region. Relying on China’s—and the world’s—largest tumor cohort data operation and follow-up center established in Tianjin, the platform serves 400,000 cancer patients.
In terms of industrial direction, medical big data continues to drive innovation. Across all stages of the drug lifecycle, LinkDoc Technology provides corresponding data support and analytics capabilities, offering comprehensive solutions. The company not only collaborates on projects with multinational pharmaceutical companies such as Roche and AstraZeneca but also further promotes medical innovation and industrial upgrading among China’s top-tier domestic pharmaceutical enterprises, including Qilu Pharmaceutical, Livzon Pharmaceutical Group, Shenyang Sunshine Pharmaceutical (Shengyang Sansheng), and Guizhou Yibai Pharmaceutical.
Zhang Tianze stated that the rapid development of LinkDoc Technology has been inseparable from government support and guidance. Currently, the LinkDoc medical big data platform has aggregated 2.8 million valid oncology patient records. “We hope to leverage this big data to facilitate effective treatment for every new cancer patient, promote new drug research and development, and build a community with a shared future for oncology patients.”
In promoting the coordinated development of the Beijing-Tianjin-Hebei region, LinkDoc Technology, with the support of Tianjin Municipality, Tianjin Binhai New Area, and the Tianjin Economic-Technological Development Area, spearheaded the establishment of the “Beijing-Tianjin-Hebei Health Big Data Industry Promotion Association.” Leveraging a “big data + industrial platform” model, it brings together medical institutions, industry regulators, and enterprises across the upstream and downstream of the medical big data industry chain to accelerate the application and development of medical big data in the Beijing-Tianjin-Hebei region and throughout China.